Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2006; 12(36): 5884-5889
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5884
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5884
Figure 1 Immunohistochemical detection of ECA39 in rectal cancers (A: × 40; B: × 100.
Bars indicate 100 μm).
Figure 2 Five-year disease-free survival curves for eligible patients with pathologic stage III cancer in the ECA39-negative group and ECA39-positive group.
Figure 3 Five-year overall survival curves for eligible patients with pathologic stage III cancer in the ECA39-negative group and ECA39-positive group.
- Citation: Yoshikawa R, Yanagi H, Shen CS, Fujiwara Y, Noda M, Yagyu T, Gega M, Oshima T, Yamamura T, Okamura H, Nakano Y, Morinaga T, Hashimoto-Tamaoki T. ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol 2006; 12(36): 5884-5889
- URL: https://www.wjgnet.com/1007-9327/full/v12/i36/5884.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i36.5884